Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1947 3
1950 10
1953 2
1955 1
1956 2
1957 1
1960 1
1961 2
1967 1
1968 1
1969 1
1970 3
1972 3
1973 7
1974 2
1975 10
1976 8
1977 9
1978 6
1979 6
1980 5
1981 8
1982 6
1983 5
1984 11
1985 11
1986 8
1987 16
1988 12
1989 15
1990 13
1991 15
1992 18
1993 9
1994 16
1995 15
1996 12
1997 13
1998 16
1999 21
2000 11
2001 33
2002 20
2003 17
2004 19
2005 23
2006 26
2007 19
2008 26
2009 29
2010 38
2011 26
2012 17
2013 21
2014 27
2015 26
2016 20
2017 21
2018 28
2019 19
2020 18
2021 21
2022 10
2023 19
2024 21
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

823 results

Results by year

Filters applied: . Clear all
Page 1
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.
Sledge GW Jr, Toi M, Neven P, Sohn J, Inoue K, Pivot X, Burdaeva O, Okera M, Masuda N, Kaufman PA, Koh H, Grischke EM, Frenzel M, Lin Y, Barriga S, Smith IC, Bourayou N, Llombart-Cussac A. Sledge GW Jr, et al. Among authors: kaufman pa. J Clin Oncol. 2017 Sep 1;35(25):2875-2884. doi: 10.1200/JCO.2017.73.7585. Epub 2017 Jun 3. J Clin Oncol. 2017. PMID: 28580882 Clinical Trial.
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, Bachelot T, Wright GS, Saura C, Escrivá-de-Romaní S, De Laurentiis M, Schwartz GN, Pluard TJ, Ricci F, Gwin WR 3rd, Levy C, Brown-Glaberman U, Ferrero JM, de Boer M, Kim SB, Petráková K, Yardley DA, Freedman O, Jakobsen EH, Gal-Yam EN, Yerushalmi R, Fasching PA, Kaufman PA, Ashley EJ, Perez-Olle R, Hong S, Rosales MK, Gradishar WJ; SOPHIA Study Group. Rugo HS, et al. Among authors: kaufman pa. J Clin Oncol. 2023 Jan 10;41(2):198-205. doi: 10.1200/JCO.21.02937. Epub 2022 Nov 4. J Clin Oncol. 2023. PMID: 36332179 Free PMC article. Clinical Trial.
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Tolaney SM, Chan A, Petrakova K, Delaloge S, Campone M, Iwata H, Peddi PF, Kaufman PA, De Kermadec E, Liu Q, Cohen P, Paux G, Wang L, Ternès N, Boitier E, Im SA. Tolaney SM, et al. Among authors: kaufman pa. J Clin Oncol. 2023 Aug 20;41(24):4014-4024. doi: 10.1200/JCO.22.02746. Epub 2023 Jun 22. J Clin Oncol. 2023. PMID: 37348019 Free PMC article. Clinical Trial.
Accommodation and presbyopia.
Croft MA, Glasser A, Kaufman PL. Croft MA, et al. Among authors: kaufman pl. Int Ophthalmol Clin. 2001 Spring;41(2):33-46. doi: 10.1097/00004397-200104000-00005. Int Ophthalmol Clin. 2001. PMID: 11290920 Review. No abstract available.
Primate glaucoma models.
Rasmussen CA, Kaufman PL. Rasmussen CA, et al. Among authors: kaufman pl. J Glaucoma. 2005 Aug;14(4):311-4. doi: 10.1097/01.ijg.0000169409.01635.bc. J Glaucoma. 2005. PMID: 15990615 Review.
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane.
Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J. Kaufman PA, et al. J Clin Oncol. 2015 Feb 20;33(6):594-601. doi: 10.1200/JCO.2013.52.4892. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605862 Free PMC article. Clinical Trial.
Grabbing the genome by the NADs.
Matheson TD, Kaufman PD. Matheson TD, et al. Among authors: kaufman pd. Chromosoma. 2016 Jun;125(3):361-71. doi: 10.1007/s00412-015-0527-8. Epub 2015 Jul 15. Chromosoma. 2016. PMID: 26174338 Free PMC article. Review.
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer.
Goetz MP, Hamilton EP, Campone M, Hurvitz SA, Cortes J, Johnston S, Llombart-Cussac A, Kaufman PA, Toi M, Jerusalem G, Graham H, Wang H, Jansen VM, Litchfield LM, Martin M. Goetz MP, et al. Among authors: kaufman pa. Clin Cancer Res. 2024 May 15;30(10):2233-2244. doi: 10.1158/1078-0432.CCR-22-3573. Clin Cancer Res. 2024. PMID: 37889120 Free PMC article. Clinical Trial.
Glaucoma Drugs in the Pipeline.
Kaufman PL, Mohr ME, Riccomini SP, Rasmussen CA. Kaufman PL, et al. Asia Pac J Ophthalmol (Phila). 2018 Sep-Oct;7(5):345-351. doi: 10.22608/APO.2018298. Epub 2018 Sep 17. Asia Pac J Ophthalmol (Phila). 2018. PMID: 30221499 Free article. Review.
823 results